Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
M Cazzola, L Calzetta, C Page, J Jardim… - European …, 2015 - Eur Respiratory Soc
In order to clarify the possible role of N-acetylcysteine (NAC) in the treatment of patients with
chronic bronchitis and chronic obstructive pulmonary disease (COPD), we have carried out …
chronic bronchitis and chronic obstructive pulmonary disease (COPD), we have carried out …
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
P Poole, K Sathananthan… - Cochrane Database of …, 2019 - cochranelibrary.com
Background Individuals with chronic bronchitis or chronic obstructive pulmonary disease
(COPD) may suffer recurrent exacerbations with an increase in volume or purulence of …
(COPD) may suffer recurrent exacerbations with an increase in volume or purulence of …
Prevention of COPD exacerbations: a European respiratory Society/American thoracic Society guideline
JA Wedzicha, PMA Calverley, RK Albert… - European …, 2017 - Eur Respiratory Soc
This document provides clinical recommendations for the prevention of chronic obstructive
pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the …
pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the …
A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease
Rationale: Chronic obstructive pulmonary disease (COPD) is often unrecognized and
untreated. Objectives: To develop a method for identifying undiagnosed COPD requiring …
untreated. Objectives: To develop a method for identifying undiagnosed COPD requiring …
Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease
AS Iyer, SP Bhatt, JJ Garner, JM Wells… - Annals of the …, 2016 - atsjournals.org
Rationale: Hospitalization for acute exacerbation of chronic obstructive pulmonary disease
(COPD) is associated with significant morbidity and health care costs, and hospitals in the …
(COPD) is associated with significant morbidity and health care costs, and hospitals in the …
Smoking cessation among US adult smokers with and without chronic obstructive pulmonary disease, 2018
Y Liu, KJ Greenlund, B VanFrank, F Xu, H Lu… - American journal of …, 2022 - Elsevier
Introduction More than 3 of 5 US adults who have ever smoked cigarettes have quit. This
study assesses the latest estimates of smoking cessation among US adults with and without …
study assesses the latest estimates of smoking cessation among US adults with and without …
[HTML][HTML] Erythromycin suppresses neutrophil extracellular traps in smoking-related chronic pulmonary inflammation
H Zhang, SL Qiu, QY Tang, X Zhou, JQ Zhang… - Cell death & …, 2019 - nature.com
Neutrophil extracellular traps (NETs) may play a critical role in smoking-related chronic
airway inflammation. However, the mechanism by which NETs induced by cigarette smoke …
airway inflammation. However, the mechanism by which NETs induced by cigarette smoke …
Effect of fluticasone furoate and vilanterol on exacerbations of chronic obstructive pulmonary disease in patients with moderate airflow obstruction
FJ Martinez, J Vestbo, JA Anderson… - American journal of …, 2017 - atsjournals.org
Rationale: Inhaled corticosteroids have been shown to decrease exacerbations in patients
with moderate to severe chronic obstructive pulmonary disease (COPD). Their effects in …
with moderate to severe chronic obstructive pulmonary disease (COPD). Their effects in …
[HTML][HTML] Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease
Y Xiaofei, L Tingting, W Xuan, H Zhiyi - Frontiers in Pharmacology, 2022 - frontiersin.org
Background and Purpose: Chronic obstructive pulmonary disease (COPD) is proposed to
hasten lung aging. Erythromycin protects against oxidative stress and inflammatory …
hasten lung aging. Erythromycin protects against oxidative stress and inflammatory …
Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians
KB Sriram, AJ Cox, RL Clancy, MPE Slack… - Critical reviews in …, 2018 - Taylor & Francis
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity
and mortality worldwide. In the lower airways of COPD patients, bacterial infection is a …
and mortality worldwide. In the lower airways of COPD patients, bacterial infection is a …